More On Leishmaniasis


Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis
From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE
Adjuvants for Leishmania vaccines: from models to clinical application
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine for use in the prevention of visceral leishmaniasis
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis

Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]